Biosimilar Market to Surpass USD 210.4 Billion by 2034, At a CAGR...

a adăugat un sunet Health

2026-04-23 09:48:55 -

The global biosimilar market is undergoing rapid transformation, supported by the increasing need for affordable and accessible treatment options for chronic and life-threatening diseases. As healthcare systems worldwide face mounting cost pressures, biosimilars are emerging as a viable alternative to expensive biologic drugs, offering similar therapeutic outcomes at significantly lower costs....

0 Commentarii 0 Distribuiri 176 Views 0 previzualizare